Prescribing Information
RYBREVANT
®
Prescribing Information
LAZCLUZE™ Prescribing Information
RYBREVANT
®
Información
de Prescripción
LAZCLUZE™ Información
de Prescripción
RYBREVANT
®
處方信息
LAZCLUZE™ 處方信息
Important Safety Information
Medical Information
For US Patients
Register for Updates
Find a J&J Specialist
This site is intended for
US healthcare professionals.
For US Healthcare Professionals
Unmet Needs
Mechanism
of Action
Clinical Trial Results
Dosage & Administration
Therapy Management
Support & Resources
For APPs & Nurses
Prescribing Information
RYBREVANT
®
Prescribing Information
LAZCLUZE™ Prescribing Information
RYBREVANT
®
Información
de Prescripción
LAZCLUZE™ Información
de Prescripción
RYBREVANT
®
處方信息
LAZCLUZE™ 處方信息
Important Safety Information
Medical Information
For US Patients
Register for Updates
Find a J&J Specialist
This site is intended for
US healthcare professionals.
For APPs
& Nurses
SITE MAP
Home
Unmet Needs
Mechanism of Action
Clinical Trial Results
First-Line
EGFR
+ mNSCLC
Second-Line
EGFR
+ mNSCLC
First-Line
EGFR
Exon20ins mNSCLC
Dosage & Administration
Premedications
RYBREVANT
®
+ LAZCLUZE™
RYBREVANT
®
+ Chemotherapy
Therapy Management
RYBREVANT
®
Monitoring & Management
Proactive Therapy Management
Support & Resources
HCP & Access Resources
Patient Support
For APPs & Nurses